Right atrial low voltage zone as a novel predictor of sinus node dysfunction in patients with non-paroxysmal atrial fibrillation

1 September 2019 (10:05 - 10:55)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Takehito Kondo

Hiroshima Heart Center, Hiroshima (Japan)

5 More presentations in this session

Presentation thumbnail

Stroke severity and subsequent mortality are worse with atrial fibrillation than in patients without atrial fibrillation

Ms N. Vinding (Copenhagen, DK)

Abstract Slides

Presentation thumbnail

Comparative safety and effectiveness of standard doses of apixaban versus dabigatran, rivaroxaban, and VKAs in non-valvular atrial fibrillation patients in France: the NAXOS study

Professor N. Danchin (Paris, FR)

Abstract Slides

Presentation thumbnail

Resumption of anticoagulant treatment in patients with atrial fibrillation following gastrointestinal bleeding: a nationwide cohort study

Miss D. Rajan (Copenhagen, DK)

Abstract Slides

Presentation thumbnail

ETNA-AF Europe: First 1-year follow-up snapshot analysis of more than 7,500 AF patients treated with edoxaban in routine clinical practice

Professor R. De Caterina (Pisa, IT)

Abstract Slides

Presentation thumbnail

Left atrial dimension and risk of cardiovascular outcomes in patients with and without atrial fibrillation: a systematic review and meta-analysis

Doctor P. Meyre (Hamilton, CA)

Abstract Slides

Access the full session

Session thumbnail

Identifying and managing complications of atrial fibrillation

The Event

ESC Congress 2019

1 September 2019 10:05 CET

You may be interested in

Congress Session

Treatment strategies for atrial fibrillation in heart failure

Congress Session

How to manage atrial fibrillation in heart failure

Congress Session

Basic science and arrhythmia pathophysiology

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources